Therapeutics and Clinical Risk Management (Apr 2018)

Oxycodone hydrochloride immediate-release analgesic for managing severe pain: abuse-deterrent formulations

  • Kibbe AH,
  • Franko TS,
  • Shah VM

Journal volume & issue
Vol. Volume 14
pp. 779 – 782

Abstract

Read online

AH Kibbe,1 TS Franko,2 VM Shah2 1Department of Pharmaceutical Sciences, Nesbitt School of Pharmacy, Wilkes University, Wilkes-Barre, PA, USA; 2Department of Clinical Pharmacy, Nesbitt School of Pharmacy, Wilkes University, Wilkes-Barre, PA, USA Abstract: This paper is an expert opinion in response to the development of abuse-deterrent immediate-release tablets containing oxycodone HCl. There is a potential impact, both positive and negative, of this type of dosage form on patients, those suffering from the disease of addiction, health care providers, and the cost of health care. Keywords: non-metabolizable polymer, opioids, risk/benefit, IV abuse, nasal abuse

Keywords